An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus

Prasarn Manitpisitkul; Christopher R. Curtin; Kevin Shalayda; Shean-Sheng Wang; Lisa Ford; Donald L. Heald

doi:10.1007/s40261-013-0143-4

An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus

Clinical Drug Investigation ◽

10.1007/s40261-013-0143-4 ◽

2013 ◽

Vol 33 (12) ◽

pp. 929-938 ◽

Cited By ~ 4

Author(s):

Prasarn Manitpisitkul ◽

Christopher R. Curtin ◽

Kevin Shalayda ◽

Shean-Sheng Wang ◽

Lisa Ford ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Drug Interaction ◽

Steady State ◽

Interaction Study ◽

Drug Interaction Study ◽

Open Label ◽

Drug Drug Interaction

Download Full-text

Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.174 ◽

2015 ◽

Vol 4 (2) ◽

pp. 121-129 ◽

Cited By ~ 12

Author(s):

Julia Zack ◽

Jolene Berg ◽

Axel Juan ◽

Nicola Pannacciulli ◽

Martine Allard ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Drug Interaction ◽

Interaction Study ◽

Drug Interaction Study ◽

Drug Drug Interaction ◽

Pharmacokinetic Drug

Download Full-text

A Pharmacokinetic/Pharmacodynamic Drug–Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs

Drug Research ◽

10.1055/s-0035-1549967 ◽

2015 ◽

Vol 66 (02) ◽

pp. 74-81 ◽

Cited By ~ 1

Author(s):

N. Kasahara ◽

H. Fukase ◽

Y. Ohba ◽

T. Saito ◽

K. Miyata ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Drug Interaction ◽

Sglt2 Inhibitor ◽

Interaction Study ◽

Drug Interaction Study ◽

Drug Drug Interaction

Download Full-text

Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus

Xenobiotica ◽

10.1080/00498254.2016.1275063 ◽

2017 ◽

Vol 48 (1) ◽

pp. 89-108 ◽

Cited By ~ 8

Author(s):

Ranjeet Prasad Dash ◽

R. Jayachandra Babu ◽

Nuggehally R. Srinivas

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Drug Interaction ◽

Interaction Potential ◽

Glucosidase Inhibitors ◽

Drug Drug Interaction ◽

Clinical Drug

Download Full-text

1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db19-1068-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1068-P

Author(s):

LIMING CHEN ◽

LINONG JI ◽

YANGANG WANG ◽

ZHONGSHU MA ◽

XINGWU RAN ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Type 2 Diabetes Mellitus ◽

Safety Profile ◽

Chinese Patients ◽

Open Label ◽

Parallel Group ◽

Free Insulin

Download Full-text

RESVERATROL SUPPLEMENTATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE, OPEN LABEL, RANDOMIZED CONTROLLED TRIAL

International Research Journal of Pharmacy ◽

10.7897/2230-8407.04849 ◽

2013 ◽

Vol 4 (8) ◽

pp. 245-249 ◽

Cited By ~ 20

Author(s):

Jayesh Kumar Bhatt ◽

Moola Joghee Nanjan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Open Label ◽

Randomized Controlled

Download Full-text

Abstract: P493 DRUG-DRUG INTERACTION STUDY TO ASSESS THE EFFECTS OF MULTIPLE DOSE OF PITAVASTATIN (LIVALO®) ON STEADY-STATE WARFARIN IN HEALTHY ADULT VOLUNTEERS

Atherosclerosis Supplements ◽

10.1016/s1567-5688(09)70788-3 ◽

2009 ◽

Vol 10 (2) ◽

pp. e806 ◽

Cited By ~ 2

Author(s):

Y Inagaki ◽

T Hunt ◽

B Arana ◽

M Gosho ◽

R Morgan

Keyword(s):

Drug Interaction ◽

Steady State ◽

Multiple Dose ◽

Healthy Adult ◽

Interaction Study ◽

Drug Interaction Study ◽

Drug Drug Interaction ◽

Adult Volunteers

Download Full-text

Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study

Journal of Endocrinological Investigation ◽

10.1007/s40618-020-01373-8 ◽

2020 ◽

Author(s):

M. Barale ◽

R. Rossetto Giaccherino ◽

E. Ghigo ◽

M. Procopio

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pilot Study ◽

Metabolic Profile ◽

Open Label ◽

Randomized Controlled

Download Full-text

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic

Download Full-text

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v2/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic

Download Full-text

Review for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v1/review1 ◽

2019 ◽

Author(s):

Graydon Meneilly

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic

Download Full-text